Incidence of severe critical events in paediatric anaesthesia in the United Kingdom : secondary analysis of the anaesthesia practice in children observational trial (APRICOT study) by Engelhardt, T. et al.
1 
 
Incidence of severe critical events in paediatric anaesthesia in the United Kingdom: 
secondary analysis of the Anaesthesia Practice In Children Observational Trial (APRICOT)  
 
 
T. Engelhardt,1 D. Ayansina,2 G.T. Bell,3 V. Oshan,4 J.S. Rutherford5 and N.S. Morton6 
 
For the APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network  
 
1 Consultant, Department of Anaesthesia, Royal Aberdeen Children’s Hospital, Aberdeen 
and Honorary Professor, Institute of Education for Medical and Dental Sciences, School of 
Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen 
2 Research Fellow, Medical Statistics Team, Institute of Applied Health Sciences, University 
of Aberdeen, Aberdeen, Scotland, UK. 
3 Consultant, Department of Anaesthesia, Royal Hospital for Children, Glasgow, Scotland 
UK. 
 
4 Consultant, Department of Anaesthesia, Royal Manchester Children’s Hospital, 
Manchester University NHS Foundation Trust, Manchester,  UK. 
 
5 Designated Paediatric Anaesthetist, Dumfries and Galloway Royal Infirmary, Dumfries, 
Scotland, UK.  
 
6 Retired Reader, Department of Paediatric Anaesthesia and Pain Management, University 
of Glasgow, Glasgow, Scotland, UK.  
 
Correspondence to: N.S. Morton 
E-mail: neilmorton@mac.com 
 
 
Short title: Severe critical events in paediatric anaesthesia in the UK 
Keywords: Paediatric anaesthesia; critical incident reporting; quality improvement 
Accepted:  
2 
 
Summary 
The Anaesthesia Practice In Children Observational Trial (APRICOT) of 31,127 patients in 261 
European hospitals revealed a high (5.2%) incidence of severe critical events (SCE) in the peri-
operative period, and wide variability in practice. A sub-analysis of the UK data was 
undertaken to investigate differences from the non-UK cohort in the incidence and nature of 
peri-operative severe critical events and to attempt to identify areas for quality improvement. 
In the UK cohort of 7,040 paediatric patients from 43 hospitals, the overall incidence of peri-
operative severe critical events was lower than in the non-UK cohort (3.3%, 95% CI: 2.9-3.8 
vs. 5.8%, 95% CI: 5.5-6.1, RR 0.57, p<0.001). There was a lower rate of bronchospasm (RR 
0.22, 95% CI: 0.14-0.33; p<0.001), stridor (RR 0.42, 95% CI: 0.28-0.65; p<0.001) and 
cardiovascular instability (RR 0.69, 95% CI: 0.55-0.86; p=0.001) than in the non-UK cohort. The 
proportion of sicker patients where less experienced teams were managing the care was 
lower in the UK than in the non-UK cohort (10.4% vs. 20.4% of the ASA physical status III and 
9% vs. 12.9% of the ASA physical status IV patients). Differences in workload between centres 
did not affect the incidence and outcomes of SCEs when stratified for age and ASA physical 
status. The lower incidence of cardiovascular and respiratory complications could be partly 
attributed to more experienced dedicated paediatric anaesthesia providers managing the 
higher risk patients in the UK.  Areas for quality improvement include: standardisation of 
serious critical event definitions; increased reporting; development of evidence-based 
protocols for management of serious critical events; development and rational use of 
paediatric peri-operative risk assessment scores; implementation of current best practice in 
provision of competent paediatric anaesthesia services in Europe; development of specific 
training in the management of severe peri-operative critical events and implementation of 
systems for ensuring maintenance of skills. 
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Introduction 
The Anaesthesia Practice In Children Observational Trial (APRICOT) was a prospective 
multicentre observational study of severe critical events during paediatric anaesthesia from 
261 hospitals in 33 European countries [1]. In 31,127 anaesthetic procedures in 30,874 
children the overall incidence of peri-operative severe critical events (SCE) was reported as 
5.2% (95% CI: 5.0-5.5) with respiratory and cardiovascular critical events predominating. The 
main risk factors identified for a severe critical event were young age, a previous medical 
history and the physical condition of the patient. A considerable variation in the incidence and 
management of severe peri-operative critical events between European countries was 
reported and has raised concerns regarding current paediatric anaesthesia training, the 
experience of the teams managing sick children, workload, resources and infrastructure [1,2].  
The UK was the largest single regional contributor to the APRICOT study, with more than 25% 
of the total patients enrolled, and the APRICOT Trial Steering Committee agreed to conduct a 
sub-analysis in order to test the hypothesis that primary outcome measures were not 
different between UK and non-UK participating centres. The primary aim of this secondary 
analysis was to detail the incidence of severe critical peri-operative events in children 
undergoing anaesthesia in the UK centres participating in APRICOT compared with the rest of 
Europe. Secondary aims were to compare the time of occurrence, type, treatment, and 
outcome of peri-operative severe critical events between the UK and non-UK centres and to 
explore the influence of hospital type, workload and experience of the anaesthetic team.     
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Methods 
Detailed methods for APRICOT have previously been published [1]. Peri-operative data that 
described the anaesthesia management, serious critical events and outcomes of children 
aged from birth to 15 years of age was prospectively collected during a consecutive two week 
period determined in advance by each centre between 1 April 2014 and 31 January 2015.  Of 
261 participating centres across 33 European countries, 43 were from the UK. (Appendix 1). 
Prior to data collection a local investigator provided details of their hospital’s paediatric 
anaesthesia activity, peri-operative care facilities, estimated annual number of procedures 
and the number of certified or dedicated paediatric anaesthetists.  
All patients undergoing an inpatient or outpatient diagnostic or surgical procedure, whether 
elective, urgent or emergency, in-hours or out-of-hours, under sedation or general 
anaesthesia, with or without regional analgesia, or under regional anaesthesia alone, were 
eligible for inclusion. Children were followed for up to 60 minutes after anaesthesia or 
sedation in the post-anaesthesia recovery unit, and the child’s status at discharge, or at 30 
days if still in hospital, was recorded. Children were excluded if they were admitted directly 
to the operating room with their tracheas already intubated, or if the anaesthesia procedure 
was performed in the neonatal or paediatric intensive care unit. 
All pre-defined severe critical events (bronchospasm, laryngospasm, pulmonary aspiration, 
drug error, anaphylaxis, cardiovascular instability, neurological damage, peri-anaesthetic 
cardiac arrest, postoperative stridor) [1] as well as their time of occurrence (during 
anaesthesia induction, maintenance, emergence or in the post-anaesthesia recovery unit), 
the treatment required and the immediate outcome were documented. Severe critical events 
were defined as those requiring immediate intervention that led, or might have led, to major 
disability or death. A detailed patient history, type of procedure, anaesthetic and airway 
management details including anaesthetic medication, the experience of the anaesthetic 
team, and postoperative care (up to 60 min) were available for further analysis. Outcome at 
hospital discharge, or at 30 days if still in hospital, was documented. 
Anonymised data were uploaded onto a secure internet-based electronic database 
(OpenClinica, Boston, MA, USA) and held by the European Society of Anaesthesiology (ESA). 
The data subset from participating UK centres was transferred securely from the ESA to the 
University of Aberdeen and analysed by a professional statistician. An a priori statistical 
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analysis plan for the UK data was approved by the APRICOT Steering Committee in 2017 after 
publication of the primary analysis of APRICOT. In APRICOT, a minimum of 25,000 patients 
were required to provide an acceptable 95% CI for the overall incidence of severe critical 
events, assuming that the lowest incidence of severe critical events was 0.1% (95% CI [0.065–
0.147]). For this UK study no a-priori power analysis was performed. However, the pre-study 
survey of UK participating centres estimated an annual paediatric anaesthesia caseload in 
2012 of over 212,000 patients. In a secondary analysis of the 2013 United Kingdom National 
Health Service (NHS) Anaesthesia Activity Survey of the Fifth National Audit Project (of the 
Royal College of Anaesthetists) the annual paediatric caseload was estimated to be 486,900 
children [11]. The APRICOT UK cohort of 7040 patients, if annualised to 183,040 represents 
38% of this estimated annual caseload. A post-hoc power analysis performed on the incidence 
of serious critical events in the UK cohort (3.3%) versus the non-UK cohort (5.8%) with 7040 
UK patients and an  of 0.01 gave a power of 100%. From these data, for a future study, a 
sample size of 1284 patients would be needed with  = 0.01 to give 95% power. 
Statistical analysis was performed using SPSS (version 24) statistical software. The 95% 
confidence intervals were computed for small proportions using the Wilson method [3]. Risk 
ratios (RR) were calculated for serious critical events in UK vs. non-UK cohorts with 
appropriate confidence intervals. Multiple logistic regression models were constructed to 
compute odds ratios and 95% confidence intervals for the effects of the type of hospital, 
experience of the anaesthesia team and the hospital case load (calculated per annum) on the 
occurrence of critical events (respiratory, cardiovascular and others). The models were 
adjusted for age of the patient and the ASA physical status (re-categorised as ASA physical 
status I and II, and ASA physical status III, IV and V). A p value of <0.05 was considered 
statistically significant. 
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Results 
The UK dataset contained details of 7092 anaesthetic procedures in 7040 children in 43 
participating centres (Table 1). For the UK cohort, the mean (SD) age was 6.2 (4.5) years with 
594 (8.4%) neonates and infants (less than 1-year-old), 3005 (42.7%) pre-school children (1–
5 years), 2505 (35.6%) schoolchildren (6–12 years), and 936 (13.3%) adolescents (13–15 
years). There were 233 severe critical events reported by UK centres, hence the incidence of 
severe critical events in the UK was 3.3% (95% CI: 2.9-3.8), which was lower (RR 0.57, 95% CI: 
0.49- 0.65; p<0.001) than the overall incidence of severe critical events in the non-UK cohort, 
which was 5.8% (95% CI: 5.5-6.1) (Table 2). The UK reported a lower rate of bronchospasm 
(RR 0.22, 95% CI: 0.14-0.33; p<0.001), stridor (RR 0.42, 95% CI: 0.28-0.65; p<0.001) and 
cardiovascular instability (RR 0.69, 95% CI: 0.55-0.86; p=0.001) than the non-UK cohort. 
Although there was a higher proportion of ASA physical status III and IV patients in the UK 
subset (15.1%) compared with the non-UK cohort (10%), the incidence of cardiovascular and 
respiratory serious critical events was lower. 
The distribution among anaesthesia teams according to ASA physical status is shown in Table 
3. In 83.8% of ASA physical status III and 83.1% of ASA physical status IV cases the patients 
were managed by dedicated paediatric anaesthesia providers in the UK as compared with 
67% of ASA physical status III and 76.5% of ASA physical status IV patients in the non-UK 
cohort. Sicker patients (ASA physical status >II), in which less experienced teams were 
managing care, comprised 10.4% of the ASA physical status III and 9% of the ASA physical 
status IV patients in the UK, while in the non-UK cohort these proportions were higher at 
20.4% and 12.9% respectively.  
The time of occurrence, type, treatment, and outcome of peri-operative severe critical events 
are shown in Table 4 (respiratory) and Table 5 (cardiovascular). 
Severe respiratory and cardiovascular critical events in the UK (as in the non-UK cohort) were 
more common at in younger patients (Figure 1). Of 130 respiratory severe critical events, 
laryngospasm was the most frequent followed by post-anaesthetic stridor, bronchospasm 
and aspiration (Figure 2, Table 4). Cardiovascular instability (n=91) was the second largest 
category of serious critical events in the UK, comprising hypotension, arrhythmias and 
bleeding (Table 5). The incidence of drug errors was low in the UK compared with the non-UK 
cohort with only four incidences reported (0.06% vs. 0.20%; RR 0.30, 95% CI: 0.11-0.84; 
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p=0.001) with two wrong drug doses and two wrong site of drug administrations each. These 
occurred at induction (n=1) and maintenance (n=3) of anaesthesia and required no further 
treatment.  
The effect of hospital type, experience of the team and annual case load per anaesthetist on 
the occurrence of critical respiratory and cardiovascular events is shown in Table 6. No effect 
of hospital type, team experience or case load was observed when adjusted for age and ASA 
physical status, with the exception of trainees having fewer critical cardiovascular events and 
mixed adults-paediatric hospitals having slightly fewer critical cardiovascular events. Younger 
age was associated with an increase in critical respiratory events. An ASA physical status of III 
or greater was associated with an increase in critical cardiovascular events.  
 
 
 
8 
 
Discussion  
 
The main strength of APRICOT is the detailed prospective capture of paediatric peri-operative 
care and outcome data, including severe critical events and their treatment, in a large number 
of European centres [1,2]. This revealed a high incidence of severe critical events and a large 
variability (Appendix 2) but similar ultimate outcomes compared with previous reports [1,2,4-
9]. The greater use of intravenous anaesthesia in the UK may explain the lower incidence of 
serious respiratory critical events at induction of anaesthesia because inhalational induction 
was shown to be associated with a higher risk in APRICOT [1,2] . Although numbers in each 
category were small, the pattern of use of bronchodilators and epinephrine for 
bronchospasm, the use of succinylcholine for laryngospasm and blood product use varied 
between the UK and non-UK cohorts and could reflect differences in training or lack of an 
evidence base for the initial management of such events. The low incidence of drug errors 
reported in the UK and Europe is encouraging but may be due to under-reporting, as a recent 
review highlighted that drug errors in paediatric anaesthesia are more frequent than in adult 
practice [10].  
The nature of voluntary participation and the snapshot method of recruitment may miss 
unusual and potentially dangerous practices and introduce reporting bias and it is also 
possible that the recruitment period of April until December may have resulted in a seasonal 
bias. However, annualised Scottish data suggests that the samples captured in the APRICOT 
recruitment period were representative of the annual paediatric caseload in Scotland. In 
APRICOT, the dataset represented 88% of all procedures in the participating centres during 
the 2-week inclusion period [1]. However, there may have been bias in patient inclusion into 
APRICOT because more than two thirds of cases came from just a quarter of the countries 
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and a follow-up analysis  of the remainder has been suggested [2]. In a recent large UK survey, 
90% of children (1–15 years old) were ASA physical status I or II and 41% were managed in 
district general hospitals. Almost all (89%) ASA physical status IV and V children, and 92% of 
infants, were managed in specialist hospitals [11]. The majority (84.8%) of the APRICOT UK 
cohort were ASA physical status I or II and 18.3% were managed in district general hospitals 
[1]. For the sicker patients, we found that a higher proportion were managed by experienced 
teams in the UK compared with the non-UK cohort, and only a few ASA physical status IV and 
V cases were managed by less experienced teams. However, when adjusted for age and ASA 
physical status, no increase in critical events was observed. It is possible that some of the staff 
were post-accreditation paediatric anaesthesia fellows or other experienced senior trainees 
acting under consultant supervision. Current advice from professional bodies is that all high 
risk paediatric cases should have direct consultant-level care by an experienced specialist 
wherever possible. The APRICOT found that senior anaesthetists had 1% fewer critical 
respiratory events per year of experience and those centres with a higher caseload had a 
lower rate of serious critical events, an inverse caseload-outcome effect which has previously 
been demonstrated [1,2,12]. This effect was not observed in the UK patient cohort. 
Triage of the sickest children to the most experienced teams is a challenge in all countries and 
relies on accurate assessment. The ASA physical status does not capture paediatric illness 
severity or anaesthesia risks very well, prompting attempts to identify high risk paediatric 
cases more accurately [7,9,13-15], and these tools need to be used more widely. 
The UK National Health Service provides children’s services in major specialist paediatric 
hospitals, large mixed adult and paediatric centres and smaller district general hospitals. 
Operational standards and training are highly regulated in the UK by government, 
professional bodies and the Royal Colleges. All healthcare professionals caring for children 
are mandated to update and maintain their paediatric knowledge and skills in order to 
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maintain their licence to practice. This may have affected the pattern of severe critical peri-
operative events and the identification of relevant organisational effects. Currently, in 
Europe, paediatric anaesthesia is not recognised as a subspecialty and training programmes 
often do not allow acquisition of sufficient paediatric skills and experience to support 
independent practice [2]. Most trainees who wish to become specialists in paediatric 
anaesthesia undertake extra training of 1 to 2 years in the form of fellowships, often including 
a component of paediatric critical care medicine training and experience. In the UK, such 
fellowships are usually locally funded and are often undertaken after training accreditation 
has been completed. In Scandinavia, a modular 2 year paediatric anaesthesia fellowship 
programme has been established very successfully. Further experience and mentoring may 
be needed in ‘superspecialties’ such as paediatric neuroanaesthesia or paediatric cardiac 
anaesthesia, and for managing complex neonates. Assessments of competence vary widely in 
Europe and there have been calls for a standardised approach to training and credentialing 
of paediatric anaesthetists in the future [2]. Having acquired the knowledge, skills and 
experience to manage children safely in the peri-operative period, maintenance of these 
competencies and re-certification processes are also needed. The UK Royal College of 
Anaesthetists has been a leader in developing a continuing education matrix which informs 
annual appraisals for all anaesthetists and is now accrediting departments of anaesthesia 
against a detailed set of standards, with paediatrics featuring throughout [16,17]. The ESPA 
and ESA are collaborating to produce a similar process in Europe. 
A strength of APRICOT was the use of detailed, standardised definitions of serious critical 
events in paediatric anaesthesia and this could form the basis of a reporting and quality 
improvement system in Europe similar to that developed in the USA [1,2,7-9,13,15,18,19]. 
Recently, a tool for reporting adverse events associated with paediatric sedation was 
developed [20] and this could be a good model to follow for peri-operative serious critical 
event reporting and quality improvement [21].  
 
The management of severe critical events varied in the UK and Europe and we suggest that 
evidence-based protocols for management of peri-operative severe critical events should be 
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implemented more widely to guide future practice. For more than 10 years, a simulation-
based educational initiative “Managing Emergencies in Paediatric Anaesthesia” (MEPA, 
www.mepa.org.uk) has been carefully validated and the curriculum for this course covers 
several of the severe critical event scenarios described in APRICOT [22]. Versions of the MEPA 
course are aimed at core basic knowledge and skill acquisition may also be adapted for more 
advanced practice and skill maintenance. These have proved highly successful and have been 
accredited by national professional bodies in several countries [22]. The MEPA scenarios have 
been run regularly as workshops during congresses of the ESPA and the Association of 
Paediatric Anaesthetists of Great Britain and Ireland (APAGBI). There is also a version of the 
course aimed at those with more occasional paediatric anaesthetic practice [22]. We suggest 
that the MEPA curriculum should in future cover all the serious critical events defined in 
APRICOT.  
Human factors play a key role in all serious critical events [10,23,24] and anaesthetic training 
in the UK now incorporates learning points from human factors analysis into the core 
curriculum and CPD for all anaesthetists. 
Ideally, preventive strategies to reduce severe critical events should be used and an important 
project is the “Safe Anaesthesia for Every Child” (Safetots) initiative (www.safetots.org) which 
promotes safe peri-operative practice by adhering to clear principles of “homeostasis” (“10-
Ns” are suggested as norms for the peri-operative period) and ensuring care is in an 
appropriate setting with adequate support and infrastructure (“5-Ws”) [25,26]. 
In conclusion, this study has shown that the UK compares favourably with a non-UK cohort in 
terms of the incidence of peri-operative severe critical events. This may be due to differences 
in organisation of paediatric services, training, clinical practices, preventative strategies and 
team culture. The engaged, enthusiastic network of paediatric anaesthetists who contributed 
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to APRICOT are already active in another detailed study of neonatal anaesthesia and are keen 
to learn from these studies and to disseminate best practice guidance to improve the care of 
children throughout Europe. 
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Table 1. Types of UK participating centres and number of patients recruited to APRICOT 
within the2 week study period. Values are median (IQR [range]). 
 
 
 
Hospital type n= 
Number of 
consultants 
Patients 
recruited 
Estimated annualised 
cases per consultant 
Paediatric 
Hospital  
10 
 
25 
(16-33 [7-37]) 
308 
(205-488 [124-
614]) 
348 
(270-583 [172-939]) 
Mixed adult-
paediatric 
Hospital 
17 
 
30 
(14-40 [3-20]) 
107 
(48-248 [8-
400]) 
93 
(58-216 [32-362]) 
District 
General 
Hospital 
16 
 
16 
(9-31 [4-36]) 
63 
(32-93 [19-
136]) 
73 
(51-180 [27-302]) 
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Table 2: Incidence  of severe critical events for UK and non-UK participating centres. 
Values are proportion (95% CI).  
 
 n 
UK 
 
 
n 
Non-UK 
 
Laryngospasm 78 1.1% 
(0.9-1.4) 
290 1.2% 
(1.1-1.4) 
Bronchospasm* 22 0.3% 
(0.2 – 0.5) 
349 1.4% 
(1.3-1.6) 
Aspiration 9 0.13% 
(0.10-0.20) 
20 0.08% 
(0.05-0.13) 
Stridor* 23 0.3% 
(0.2-0.5) 
185 0.8% 
(0.7-0.9) 
Cardiovascular 
instability* 
92 1.3% 
(1.1-1.6) 
457 1.9% 
(1.7-2.1) 
Anaphylaxis 0 0% 3 0.012% 
(0.01-0.04) 
Neurological 
damage 
2 0.03% 
(0.01-0.10) 
3 0.012% 
(0.01-0.04) 
Drug error 4 0.06% 
(0.20-0.15) 
45 0.2% 
(0.10-0.30) 
Overall* 233 3.3% 
(2.9-3.8) 
1404 5.8% 
(5.5-6.1) 
 
 
*95% CI for the UK data does not overlap with that of the non-UK data
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Table 3: Distribution of cases among anaesthesia teams according to ASA physical status for 
UK and non-UK patients. Specialists are anaesthetists with mainly (>80%) paediatric cases, 
Frequent are specialist anaesthetists with frequent (50–80%) paediatric anaesthesia cases, 
Occasional are specialist anaesthetists with occasional (<50%) paediatric anaesthesia cases 
and Training are anaesthetists in training, anaesthetic nurses or technicians. Values are 
number (proportion). 
 
 
 
 
Total* 
  
Specialist Frequent Occasional Training 
ASA I    UK 
 
4343 
(61.7%) 
 
2089  
(48.1%) 
 
589  
(13.6%) 
 
1126  
(25.9%) 
 
539  
(12.4%) 
Non-UK 14540 
(60.4%) 
8093 
(55.7%) 
2274 
(15.6%) 
3108 
(21.4%) 
1062 
(7.3%) 
ASA II   UK  
1624 
(23.1%) 
1107  
(68.2%) 
178  
(11%) 
196  
(12.1%) 
143  
(8.8%) 
Non-UK 7115 
(29.5%) 
4522 
(63.6%) 
950 
(13.4%) 
1178 
(16.6%) 
465 
(6.5%) 
ASA III  UK  
889 
(12.6%) 
745  
(83.8%) 
52  
(5.8%) 
39  
(4.4%) 
53  
(6%) 
Non-UK 2098  
(8.7%) 
1404 
(67.0%) 
266 
(12.7%) 
276 
(13.2%) 
151 
(7.2%) 
ASA IV  UK  
178 
(2.5%) 
148  
(83.1%) 
14  
(7.9%) 
8  
(4.5%) 
8  
(4.5%) 
Non-UK 320  
(1.4%) 
245 
(76.6%) 
34 
(10.6%) 
36 
(11.3%) 
5 
(1.6%) 
ASA V   UK  
5 
(0.1%) 
5  
(100%) 
0  
(0%) 
0  
(0%) 
0  
(0%) 
Non-UK 7 
(0%) 
6 
(85.7%) 
1 
(14.3%) 
0 
(0%) 
0 
(0%) 
Total    UK 7039 
(100%) 
4094 
(58.2%) 
833 
(11.8%) 
1369 
(19.4%) 
743 
(10.6%) 
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Non-UK 24080 
(100%) 
14270 
(59.3%) 
3525 
(14.6%) 
4598 
(19.1%) 
1683 
(7.0%) 
ASA, ASA physical status 
*refers to the number (proportion) of UK or non-UK patients in each ASA physical status 
group. 
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Table 4. Severe respiratory critical events, their time of occurrence, type, treatment and outcome. Patients 
may have suffered more than one severe respiratory event at any one time and received more than one 
treatment. Values are number (proportion). 
 Laryngospasm  Bronchospasm  Aspiration  Stridor 
  
UK 
n=76 
non-UK 
n=292 
UK 
n=21 
non-UK 
n=350 
UK 
n=9 
non-UK 
n=20 
UK 
n=24 
non-UK 
n=184 
Time of occurrence               
Induction 
30  
(39.5%) 
102 
(34.9%) 
2  
(9.5%) 
116 
(33.1%) 
3 
(33.3%) 
10  
(50%) 
  
Maintenance 
21  
(27.6%) 
48  
(16.4%) 
10 
(47.6%) 
89  
(25.4%) 
4 
(44.4%) 
4  
(20%) 
  
Awakening 
22  
(28.9%) 
143 
(49.0%) 
8  
(38.1) 
159 
(45.4%) 
2 
(22.2%) 
6  
(30%) 
16 
(66.6%) 
141 
(76.6%) 
Post-anaesthesia care unit 
3  
(3.9%) 
9  
(3.1%) 
1  
(4.8%) 
15  
(4.3%) 
 
2  
(10%) 
12 
(50.0%) 
55  
(29.9%) 
Treatment                 
Propofol 
60  
(78.9%) 
195 
(66.8%) 
      
Succinylcholine 23 (30.3%) 46 (15.8%)       
Intubation/prolonged 
intubation 
16  
(21.1%) 
57  
(19.5%) 
3 
(14.2%) 
53  
(15.1%) 
4 
(44.4%) 
   
Bronchodilators   
9 
(42.6%) 
215 
(61.4%) 
 
13  
(65%) 
  
Epinephrine   
3 
(14.2%) 
16 ( 
4.6%) 
  
5 
(20.9%) 
49  
(27.2%) 
Deepening anaesthesia   
3 
(14.2%) 
82  
(23.4%) 
    
Tracheobronchial suction     
8 
(88.8%) 
15  
(75%) 
  
Antibiotics      
2  
(10%) 
  
CPAP     
1 
(11.1%) 
 
13 
(54.1%) 
71  
(38.6%) 
Intravenous steroids       
4 
(16.6%) 
27  
(14.7%) 
Other treatments 
10  
(13.2%) 
78  
(26.7%) 
7 
(33.3%) 
73  
(20.9%) 
  
8 
(33.3%) 
55  
(29.9%) 
Outcome         
Uneventful 
75  
(98.7%) 
283 
(96.9%) 
14 
(66.6%) 
202 
(57.7%) 
7 
(77.8%) 
11  
(55%) 
20 
(83.3%) 
178 
(96.7%) 
Intubation/prolonged 
intubation 
1  
(1.3%) 
8  
(2.7%) 
 
11  
(3.1%) 
 
4  
(20%) 
2  
(8.3%) 
7  
(3.8%) 
Pulmonary oedema  
1  
(0.3%) 
      
Hypoxaemia   
6 
(28.5%) 
139 
(39.7%) 
2 
(22.2%) 
8  
(40%) 
  
Admission intensive care    1 (4.8%) 1 (0.3%)     
Pneumonia      1 (5%)   
Tracheostomy       1 (4.2%)  
Other    5 (1.4%)     
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Table 5. Severe cardiovascular critical events, their time of occurrence, type, treatment and outcome. Patients 
may have suffered more than one severe event at any one time and received more than one treatment. Values 
are number (proportion).  
Severe cardiovascular events  
 
UK 
n=91 
non-UK 
n=458 
Time of occurrence 
  
Induction 27 (27.6%) 116 (20.9%) 
Maintenance 66 (67.3%) 388 (69.8) 
Awakening 2 (2.0%) 30 (5.3%) 
Post-anaesthesia care unit 3 (3.1%) 22 (4.0%) 
Type of event 
  
Bleeding 14 (15.4%) 98 (21.4%) 
Arrhythmia (all) 32 (35.2%) 104 (22.7%) 
Arrhythmia (bradycardia) 15 (16.5%) 71 (15.5%) 
Arrhythmia (ventricular tachycardia) 1 (1.1%) 1 (<0.1%) 
Arrhythmia (ventricular fibrillation) 1 (1.1%) 
 
Hypotension 50 (54.9%) 334 (72.9%) 
Vasodilation 6 (6.6%) 31 (6.8%) 
Hypertension 2 (2.2%) 5 (1.1%) 
Cardiac dysfunction 1 (1.1%) 3 (0.1%) 
Myocardial ischaemia 
 
2 (<0.1%) 
Miscellaneous 2 (2.2%) 12 (2.6%) 
Treatment 
  
Fluid resuscitation 50 (54.9%) 266 (58.1%) 
Blood products 12 (13.2%) 112 (24.5%) 
Fluids and blood products§ 11 (12.1%) 18 (3.9%) 
Vasopressors 36 (39.6%) 265 (57.9%) 
Fluids/blood products and vasopressors§ 26 (28.6%) 159 (34.7%) 
Atropine 20 (22.0%) 118 (25.8%) 
Defibrillation 4 (4.4%) 4 (0.9%) 
Other treatments 14 (15.4%) 37 (8.1%) 
Outcome 
  
Uneventful 85 (93.4%) 391 (85.4%) 
Cardiac arrest 3 (3.3%) 5 (1.1%) 
Coagulopathy 2 (2.2%) 17 (3.7%) 
Extracorporeal membrane oxygenation 1 (1.1%) 1 (<0.1%) 
Myocardial ischaemia 
 
1 (<0.1%) 
Admission intensive care  1 (1.1%) 4 (0.9%) 
Reoperation for haemostasis 
 
2 (<0.4%) 
§Subgroup of children who received both interventions for cardiovascular critical events 
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Table 6. Workload, influence of hospital type, experience of team and annual case load per 
anaesthetist on the occurrence of critical respiratory and cardiovascular events when 
adjusted for age and ASA physical status. Values are odds ratio (95% CI)  
 Critical 
respiratory 
event 
Critical 
cardiovascular 
event 
Total 
critical events 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Hospital type    
Paediatric Hospital  1 1 1 
Mixed adult-
paediatric Hospital 
0.92 
(0.54-1.53) 
0.46 *  
(0.22-0.99) 
0.67  
(0.44-1.01) 
 
District General 1.04 
(0.47-2.26) 
1.59  
(0.48- 5.26) 
1.05  
(0.55- 2) 
Experience    
Specialist 1 1 1 
Frequent 1.09  
(0.57- 2.07) 
0.56  
(0.21- 1.47) 
0.83  
(0.49- 1.41) 
Occasional 1.43  
(0.75- 2.71) 
0.38  
(0.12- 1.16) 
0.86  
(0.49- 1.5) 
Training 1.08  
(0.55- 2.08) 
0.21 * 
(0.05- 0.89)  
0.72  
(0.41- 1.25) 
Case load    
<100 pa 1 1 1 
100-200 pa 1.37  
(0.66-2.84) 
0.98  
(0.34- 2.81) 
1.11  
(0.6- 2.03) 
>200 pa 1.27  
(0.68- 2.38) 
0.75  
(0.29- 1.87) 
1.02  
(0.61- 1.7) 
ASA    
ASA I & 2 1 1 1 
ASA III-V 1.12  
(0.67-1.86) 
4.54 ** 
(2.83-7.28) 
2.0 ** 
(1.43-2.8) 
Age            (months) 0.99 ** 
(0.986- 0.994) 
1 
(0.998-1.006) 
0.995 ** 
(0.992-0.998) 
    
*p<0.05, **p<0.001 
Specialist - anaesthetist with mainly (>80%) paediatric cases; Frequent - Specialist 
anaesthetist with frequent (50–80%) paediatric anaesthesia cases; Occasional - Specialist 
anaesthetist with occasional (<50%) paediatric anaesthesia cases; Training - Anaesthetist in 
training, anaesthetic nurse, or technician); ASA, ASA physical status. 
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Legends for figures 
 
Figure 1:  
The incidence of severe respiratory (striped) and cardiovascular (solid) critical events 
according to age of the patient 
Figure 2 
The types of critical respiratory event (solid – laryngospasm, striped – stridor, dotted – 
bronchospasm, no fill – aspiration). 
 


